Fulton Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
2,578
-229
| -8% | -$120K | 0.05% | 238 |
|
|
2025
Q1 | $1.78M | Sell |
2,807
-258
| -8% | -$164K | 0.07% | 194 |
|
|
2024
Q4 | $2.18M | Sell |
3,065
-307
| -9% | -$219K | 0.08% | 173 |
|
|
2024
Q3 | $3.54M | Sell |
3,372
-550
| -14% | -$578K | 0.14% | 113 |
|
|
2024
Q2 | $4.12M | Buy |
3,922
+58
| +2% | +$61K | 0.17% | 96 |
|
|
2024
Q1 | $3.72M | Buy |
3,864
+111
| +3% | +$107K | 0.15% | 107 |
|
|
2023
Q4 | $3.3M | Sell |
3,753
-205
| -5% | -$180K | 0.15% | 113 |
|
|
2023
Q3 | $3.26M | Buy |
3,958
+95
| +2% | +$78.2K | 0.16% | 107 |
|
|
2023
Q2 | $2.78M | Sell |
3,863
-393
| -9% | -$282K | 0.14% | 127 |
|
|
2023
Q1 | $3.5M | Buy |
4,256
+253
| +6% | +$208K | 0.18% | 101 |
|
|
2022
Q4 | $2.89M | Buy |
4,003
+318
| +9% | +$229K | 0.16% | 119 |
|
|
2022
Q3 | $2.54M | Buy |
3,685
+518
| +16% | +$357K | 0.15% | 125 |
|
|
2022
Q2 | $1.87M | Buy |
3,167
+26
| +0.8% | +$15.4K | 0.1% | 156 |
|
|
2022
Q1 | $2.19M | Buy |
3,141
+96
| +3% | +$67.1K | 0.1% | 152 |
|
|
2021
Q4 | $1.92M | Buy |
3,045
+277
| +10% | +$175K | 0.08% | 164 |
|
|
2021
Q3 | $1.68M | Buy |
2,768
+82
| +3% | +$49.6K | 0.08% | 171 |
|
|
2021
Q2 | $1.5M | Buy |
+2,686
| New | +$1.5M | 0.07% | 182 |
|